Odisha Government has secured investment commitments worth Rs 1 lakh crore at Odisha Investors’ Meet Roadshow at Kolkata in West Bengal.
The proposed investments are expected to generate close to 90,000 jobs. 27 MoUs were signed with an investment potential of Rs 81,864 crore, generating over 63,161 jobs. Similarly, 19 investment intent proposals were received, amounting to Rs 18,453 crore, with the potential to create over 27,591 employment opportunities.
Addressing the Odisha Investors’ Meet Roadshow, Chief Minister Mohan Majhi invited industry leaders to partner with Odisha, stating that growth in the East will not be competitive, but collaborative, with states complementing each other’s strengths to build a strong eastern industrial corridor.
He highlighted Odisha’s strategic coastline and ports at Paradip, Dhamra, and Gopalpur as key enablers of port-led industrialisation serving eastern and central India.
This significant investment is part of Odisha’s vision to emerge as the industrial growth engine of eastern India, under its Purvodaya vision and long-term development roadmap.
The Odisha Investors’ Meet Roadshow in Kolkata saw participation from over 500 industry leaders, business associations, and institutional stakeholders, offering a comprehensive view of Odisha’s industrial ecosystem, infrastructure readiness, and policy-driven growth model.
Addressing the gathering, the CM presented his vision for Samruddha Odisha by 2036 and outlined a clear roadmap for the growth of the manufacturing and services sectors. He highlighted opportunities across renewable energy equipment, textiles, pharmaceuticals, electronics, IT, data centres, and advanced manufacturing, the Chief Minister invited industry especially from West Bengal, Jharkhand, and the North-Eastern states to expand, diversify, and grow with Odisha.
The Kolkata engagements covered a wide spectrum of sectors including Hosiery, Apparel Accessories & Technical Textile, Metal Ancillary, Downstream & Engineering Goods, Plastic, Chemical, Packaging & Recycling, Pharmaceuticals, Medical Devices & Biotech.
